ストックスクリーナーアプリを入手
109.14
5.60%
-6.47
アフターアワーズ：
108.05
-1.09
-1.00%
Insmed Inc (INSM) 最新ニュース
Enterprise value to EBIT forward of Insmed Incorporated – BMV:INSM - TradingView
INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study - Stocktwits
MSN Money - MSN
What's Driving Insmed's Recent Volatility - Kavout | AI
Enterprise value to revenue forward of Insmed Incorporated – BMV:INSM - TradingView
Insmed CEO William Lewis sells over $1.25m in company stock By Investing.com - Investing.com India
Insmed Insider Sold Shares Worth $1,256,084, According to a Recent SEC Filing - Moomoo
Insmed CEO William Lewis sells over $1.25m in company stock - Investing.com
Form 4 Insmed Inc For: 10 July By Investing.com - Investing.com South Africa
INSMED Inc (NASDAQ: INSM) CEO executes 10b5-1 option exercise and sale of 10,699 shares - Stock Titan
INSM Reiterated by Guggenheim -- Price Target Maintained at $207 - GuruFocus
Insmed Slides 4% as Investors Weigh Insider Filing and Near-Term Catalyst Gap - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Form 144 INSMED INC For: 9 July By Investing.com - Investing.com India
INSM (NASDAQ: INSM) affiliate William Lewis reports multiple share sales - Stock Titan
INSM Technical Analysis & Stock Price Forecast - Intellectia AI
Insmed CMO Martina Flammer sells $1.35m in stock - Investing.com
Insmed (NASDAQ:INSM) Drug Launch Fuels Healthcare Market Buzz - Kalkine Media
Form 4 Insmed Inc For: 8 July By Investing.com - Investing.com South Africa
Insmed CMO Martina Flammer sells $1.35m in stock By Investing.com - Investing.com South Africa
Insmed (INSM) CMO sells 12,302 shares after option exercises - Stock Titan
Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $212 - Moomoo
INSM, FSLR, APTV: Dreaded Death Cross Has Formed On These Stocks — What It Means For Investors - Stocktwits
Non-Cystic Fibrosis Bronchiectasis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2036 – DelveInsight | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farma - Barchart.com
Martina Flammer reports multiple INSM (NASDAQ: INSM) share dispositions in Form 144 - Stock Titan
INSMInsmed Inc Options - Finviz
Insmed Q1 2026 slides: BRINSUPRI surges 44%, ARIKAYCE expansion ahead - Investing.com
Here’s Why TimesSquare Mid Cap Growth Strategy Added Insmed (INSM) - Yahoo Finance
Analysts Expect Breakeven For Insmed Incorporated (NASDAQ:INSM) Before Long - Moomoo
Insmed’s New Lung Disease Study Data A Win For Company, Says Analyst - Stocktwits
Insmed Incorporated(NasdaqGS: INSM) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Insmed Incorporated(NasdaqGS:INSM) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Insmed Incorporated(NasdaqGS: INSM) dropped from Russell 3000 Value Benchmark - marketscreener.com
Insmed Incorporated(NasdaqGS: INSM) dropped from Russell 2500 Index - marketscreener.com
Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM) - Yahoo Finance
Insmed Incorporated(NasdaqGS: INSM) dropped from Russell Midcap Value Benchmark - marketscreener.com
Insmed Inc (INSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Insmed Insider Sold Shares Worth $2,210,763, According to a Recent SEC Filing - marketscreener.com
INSMED (INSM) CEO Lewis exercises options and sells 21,398 shares under 10b5-1 plan - Stock Titan
Price to earnings forward of Insmed Incorporated – NASDAQ:INSM - TradingView
Form 144 INSMED INC For: 25 June - Investing.com UK
Form 144 INSMED INC For: 25 June By Investing.com - Investing.com Nigeria
Insmed Incorporated Actuals & Estimates (NASDAQ:INSM) - TradingView
Insmed Incorporated Actuals & Estimates (BX:IM8N) - TradingView
William Lewis files Form 144 — Insmed (NASDAQ: INSM) reports recent share dispositions - Stock Titan
Insmed | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Enterprise value to EBITDA forward of Insmed Incorporated – NASDAQ:INSM - TradingView
4.06%
0.04%
大文字化:
|
ボリューム (24 時間):